Market Overview

Benzinga's Top Initiations

Related HSH
Tyson Foods Investors Should Be Happy, Stephens Analyst Says
4 Kraft Divisions Ripe For Spinoff (And Some Possible Suitors)
Related SGEN
Seattle Genetics Announces Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Combination with Opdivo® (Nivolumab) in Second-line Hodgkin Lymphoma
American Eagle Outfitters, Sears And Others That Insiders Have Been Buying
Premarket Biotech Digest: Evoke Pharma Rallies, Avelumab Fast Tracked, Vertex's Milestone (Seeking Alpha)

Analysts at KeyBanc Capital initiated coverage on shares of Hillshire Brands Company (NYSE: HSH) with a “hold” rating. Hillshire Brands' shares closed at $29.99 on Tuesday. Hillshire Brands' PEG ratio is 4.24.

ThinkEquity initiated coverage on shares of Seattle Genetics (NASDAQ: SGEN) with a “buy” rating. Seattle Genetics' stock closed at $25.80 on Tuesday. Seattle Genetics' trailing-twelve-month revenue is $130.85 million.

Latest Ratings for HSH

Jun 2014Wells FargoDowngradesOutperformMarket Perform
May 2014BernsteinDowngradesOutperformMarket Perform
May 2014BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for HSH
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (SGEN + HSH)

Get Benzinga's Newsletters